Bristol-Myers Squibb Company (BMY) Stock

Bristol-Myers Squibb Company (BMY) is a Healthcare stock trading at $54.00 (as of 2026-06-18), with a market capitalization of $111.21B and a trailing P/E of 16.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Bristol-Myers Squibb Company develops, licenses, manufactures, and markets biopharmaceutical products worldwide. Its portfolio covers areas such as hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and COVID-19, and includes therapies including Revlimid, Eliquis, Opdivo, Pomalyst/Imnovid, and Orencia.

Valuation — source: SEC EDGAR (first-party)
Price$54.00
Market Cap$111.21B
P/E Ratio16.0
EV / EBITDA11.5
Price / Book5.80
Price / Sales2.41
Dividend Yield4.3%
DCF Value (model)$70.47
DCF Upside vs Price30.5%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$48.19B
Net Margin14.6%
Return on Equity36.2%
Debt / Equity2.21
Current Ratio1.42
Revenue Growth (YoY)2.6%
EPS Growth (YoY)8.3%
FCF Growth (YoY)-55.3%
Financial Health — source: SEC EDGAR
Altman Z-Score2.14 (grey)
Piotroski F-Score8/9 (strong)
Valuation vs Sector & Industry
Stock P/E16.0
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-23.6%
vs Industry-7.3%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($10.72B)
Institutional Holders Tracked10
Congressional Trades (recent)10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOChristopher S. Boerner
Employees34,100
CountryUS
IPO Date1972-06-01

Related Companies (Business model: Big Pharma / Branded Drugs; 8 closest by market cap; US-domiciled)

  • AbbVie Inc. (ABBV)
  • Merck & Co., Inc. (MRK)
  • Abbott Laboratories (ABT)
  • Amgen Inc. (AMGN)
  • Gilead Sciences, Inc. (GILD)
  • Pfizer Inc. (PFE)
  • Regeneron Pharmaceuticals, Inc. (REGN)
  • Biogen Inc. (BIIB)
BMY earnings history · BMY institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.